Transcutaneous bilirubin estimation in extremely low birth weight infants receiving phototherapy: A prospective observational study

Vidit Bhargava, Daniel Tawfik, Bruce Niebuhr, Sunil Jain

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Measurement of transcutaneous bilirubin (TcB) is a quick, reliable and painless method to guide management of hyperbilirubinemia. Studies in term and late preterm infants have found that TcB measurements from covered areas (TcB-C) during phototherapy (PHT) co-relate well with serum bilirubin levels. Limited data exists in extremely low birth weight (ELBW) infants. Methods: In this prospective observational study, an opaque patch was placed on the back of an ELBW infant prior to initiation of PHT. TcB-C and TcB-E (TcB from exposed area) levels were measured at birth and at 24-h intervals for 5 days. Total serum bilirubin (TSB) levels were also measured within 30 min of obtaining TcB levels. A Wilcoxon signed rank test was used for data analysis. A mixed effect model was used to adjust for repeated measurements over time. The p value < 0.05 was considered significant. Results: A total of 19 infants were enrolled in the study, with a mean gestational age of 26 ± 2 weeks and mean weight 827 ± 127 g. The difference between TcB-C and TSB was 2.68 ± 2.41 mg/dl (mean ± SD, p < 0.001). In contrast, the difference between TcB-E and TSB was - 0.51 ± 1.74 mg/dl (p = 0.02). TcB-C consistently overestimates TSB, while TcB-E consistently underestimates TSB. Conclusions: During PHT exposure, TcB-C does not correlate with TSB values in ELBW infants. TcB-C levels cannot be used as a surrogate for TSB measurement in ELBW infants.

Original languageEnglish (US)
Article number227
JournalBMC Pediatrics
Volume18
Issue number1
DOIs
StatePublished - Jul 10 2018

Fingerprint

Extremely Low Birth Weight Infant
Phototherapy
Bilirubin
Observational Studies
Prospective Studies
Serum

Keywords

  • ELBW
  • Hyperbilirubinemia
  • Kernicterus
  • Transcutaneous bilirubinometry

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Transcutaneous bilirubin estimation in extremely low birth weight infants receiving phototherapy : A prospective observational study. / Bhargava, Vidit; Tawfik, Daniel; Niebuhr, Bruce; Jain, Sunil.

In: BMC Pediatrics, Vol. 18, No. 1, 227, 10.07.2018.

Research output: Contribution to journalArticle

@article{c46ebdccbe2043c18c8158b0bd16cb22,
title = "Transcutaneous bilirubin estimation in extremely low birth weight infants receiving phototherapy: A prospective observational study",
abstract = "Background: Measurement of transcutaneous bilirubin (TcB) is a quick, reliable and painless method to guide management of hyperbilirubinemia. Studies in term and late preterm infants have found that TcB measurements from covered areas (TcB-C) during phototherapy (PHT) co-relate well with serum bilirubin levels. Limited data exists in extremely low birth weight (ELBW) infants. Methods: In this prospective observational study, an opaque patch was placed on the back of an ELBW infant prior to initiation of PHT. TcB-C and TcB-E (TcB from exposed area) levels were measured at birth and at 24-h intervals for 5 days. Total serum bilirubin (TSB) levels were also measured within 30 min of obtaining TcB levels. A Wilcoxon signed rank test was used for data analysis. A mixed effect model was used to adjust for repeated measurements over time. The p value < 0.05 was considered significant. Results: A total of 19 infants were enrolled in the study, with a mean gestational age of 26 ± 2 weeks and mean weight 827 ± 127 g. The difference between TcB-C and TSB was 2.68 ± 2.41 mg/dl (mean ± SD, p < 0.001). In contrast, the difference between TcB-E and TSB was - 0.51 ± 1.74 mg/dl (p = 0.02). TcB-C consistently overestimates TSB, while TcB-E consistently underestimates TSB. Conclusions: During PHT exposure, TcB-C does not correlate with TSB values in ELBW infants. TcB-C levels cannot be used as a surrogate for TSB measurement in ELBW infants.",
keywords = "ELBW, Hyperbilirubinemia, Kernicterus, Transcutaneous bilirubinometry",
author = "Vidit Bhargava and Daniel Tawfik and Bruce Niebuhr and Sunil Jain",
year = "2018",
month = "7",
day = "10",
doi = "10.1186/s12887-018-1207-7",
language = "English (US)",
volume = "18",
journal = "BMC Pediatrics",
issn = "1471-2431",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Transcutaneous bilirubin estimation in extremely low birth weight infants receiving phototherapy

T2 - A prospective observational study

AU - Bhargava, Vidit

AU - Tawfik, Daniel

AU - Niebuhr, Bruce

AU - Jain, Sunil

PY - 2018/7/10

Y1 - 2018/7/10

N2 - Background: Measurement of transcutaneous bilirubin (TcB) is a quick, reliable and painless method to guide management of hyperbilirubinemia. Studies in term and late preterm infants have found that TcB measurements from covered areas (TcB-C) during phototherapy (PHT) co-relate well with serum bilirubin levels. Limited data exists in extremely low birth weight (ELBW) infants. Methods: In this prospective observational study, an opaque patch was placed on the back of an ELBW infant prior to initiation of PHT. TcB-C and TcB-E (TcB from exposed area) levels were measured at birth and at 24-h intervals for 5 days. Total serum bilirubin (TSB) levels were also measured within 30 min of obtaining TcB levels. A Wilcoxon signed rank test was used for data analysis. A mixed effect model was used to adjust for repeated measurements over time. The p value < 0.05 was considered significant. Results: A total of 19 infants were enrolled in the study, with a mean gestational age of 26 ± 2 weeks and mean weight 827 ± 127 g. The difference between TcB-C and TSB was 2.68 ± 2.41 mg/dl (mean ± SD, p < 0.001). In contrast, the difference between TcB-E and TSB was - 0.51 ± 1.74 mg/dl (p = 0.02). TcB-C consistently overestimates TSB, while TcB-E consistently underestimates TSB. Conclusions: During PHT exposure, TcB-C does not correlate with TSB values in ELBW infants. TcB-C levels cannot be used as a surrogate for TSB measurement in ELBW infants.

AB - Background: Measurement of transcutaneous bilirubin (TcB) is a quick, reliable and painless method to guide management of hyperbilirubinemia. Studies in term and late preterm infants have found that TcB measurements from covered areas (TcB-C) during phototherapy (PHT) co-relate well with serum bilirubin levels. Limited data exists in extremely low birth weight (ELBW) infants. Methods: In this prospective observational study, an opaque patch was placed on the back of an ELBW infant prior to initiation of PHT. TcB-C and TcB-E (TcB from exposed area) levels were measured at birth and at 24-h intervals for 5 days. Total serum bilirubin (TSB) levels were also measured within 30 min of obtaining TcB levels. A Wilcoxon signed rank test was used for data analysis. A mixed effect model was used to adjust for repeated measurements over time. The p value < 0.05 was considered significant. Results: A total of 19 infants were enrolled in the study, with a mean gestational age of 26 ± 2 weeks and mean weight 827 ± 127 g. The difference between TcB-C and TSB was 2.68 ± 2.41 mg/dl (mean ± SD, p < 0.001). In contrast, the difference between TcB-E and TSB was - 0.51 ± 1.74 mg/dl (p = 0.02). TcB-C consistently overestimates TSB, while TcB-E consistently underestimates TSB. Conclusions: During PHT exposure, TcB-C does not correlate with TSB values in ELBW infants. TcB-C levels cannot be used as a surrogate for TSB measurement in ELBW infants.

KW - ELBW

KW - Hyperbilirubinemia

KW - Kernicterus

KW - Transcutaneous bilirubinometry

UR - http://www.scopus.com/inward/record.url?scp=85049840102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049840102&partnerID=8YFLogxK

U2 - 10.1186/s12887-018-1207-7

DO - 10.1186/s12887-018-1207-7

M3 - Article

C2 - 29991353

AN - SCOPUS:85049840102

VL - 18

JO - BMC Pediatrics

JF - BMC Pediatrics

SN - 1471-2431

IS - 1

M1 - 227

ER -